This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of California. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations by Philipp N Spahn in Glycosylation Prediction
Introduction
Philipp N Spahn is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of biopharmaceuticals through his innovative work on glycosylation prediction. His research focuses on optimizing the production of therapeutic proteins, which is crucial for advancing medical treatments.
Latest Patents
Philipp N Spahn holds a patent for "Systems and methods for predicting glycosylation on proteins." This technology provides a computational prediction model that utilizes a novel algorithm to predict glycosylation and optimize biopharmaceutical production. The model can predict glycosylation changes based solely on the starting glycoprofiles in any host cells, along with known or suggested rules on enzyme specificity. The applications of this invention model are extensive and hold promise for improving therapeutic protein production.
Career Highlights
Philipp N Spahn is affiliated with the University of California, where he continues to advance his research in biopharmaceuticals. His work has garnered attention for its potential impact on the efficiency and effectiveness of protein-based therapies. With 1 patent to his name, he is recognized for his innovative approach to solving complex problems in the field.
Collaborations
Philipp collaborates with Nathan E Lewis, contributing to the advancement of research in glycosylation and its implications for biopharmaceuticals.
Conclusion
Philipp N Spahn's innovative work in predicting glycosylation represents a significant advancement in the field of biopharmaceuticals. His contributions are paving the way for more effective therapeutic protein production, which could have a lasting impact on medical treatments.